210 related articles for article (PubMed ID: 20967591)
1. Selecting a mouse model of Alzheimer's disease.
Chin J
Methods Mol Biol; 2011; 670():169-89. PubMed ID: 20967591
[TBL] [Abstract][Full Text] [Related]
2. Plaques, tangles, and memory loss in mouse models of neurodegeneration.
Eriksen JL; Janus CG
Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mouse models of Alzheimer's disease: phenotype and application.
Higgins GA; Jacobsen H
Behav Pharmacol; 2003 Sep; 14(5-6):419-38. PubMed ID: 14501255
[TBL] [Abstract][Full Text] [Related]
5. A decade of modeling Alzheimer's disease in transgenic mice.
McGowan E; Eriksen J; Hutton M
Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
[TBL] [Abstract][Full Text] [Related]
6. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: Abeta, tau and synaptic dysfunction.
LaFerla FM; Oddo S
Trends Mol Med; 2005 Apr; 11(4):170-6. PubMed ID: 15823755
[TBL] [Abstract][Full Text] [Related]
8. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
Phivilay A; Julien C; Tremblay C; Berthiaume L; Julien P; Giguère Y; Calon F
Neuroscience; 2009 Mar; 159(1):296-307. PubMed ID: 19135506
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
10. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
11. Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes.
David DC; Ittner LM; Gehrig P; Nergenau D; Shepherd C; Halliday G; Götz J
Proteomics; 2006 Dec; 6(24):6566-77. PubMed ID: 17111439
[TBL] [Abstract][Full Text] [Related]
12. Transplanted astrocytes internalize deposited beta-amyloid peptides in a transgenic mouse model of Alzheimer's disease.
Pihlaja R; Koistinaho J; Malm T; Sikkilä H; Vainio S; Koistinaho M
Glia; 2008 Jan; 56(2):154-63. PubMed ID: 18004725
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
[TBL] [Abstract][Full Text] [Related]
14. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
[TBL] [Abstract][Full Text] [Related]
15. Histochemical visualization and diffusion MRI at 7 Tesla in the TgCRND8 transgenic model of Alzheimer's disease.
Thiessen JD; Glazner KA; Nafez S; Schellenberg AE; Buist R; Martin M; Albensi BC
Brain Struct Funct; 2010 Jul; 215(1):29-36. PubMed ID: 20512361
[TBL] [Abstract][Full Text] [Related]
16. Anatomical and functional phenotyping of mice models of Alzheimer's disease by MR microscopy.
Benveniste H; Ma Y; Dhawan J; Gifford A; Smith SD; Feinstein I; Du C; Grant SC; Hof PR
Ann N Y Acad Sci; 2007 Feb; 1097():12-29. PubMed ID: 17413006
[TBL] [Abstract][Full Text] [Related]
17. Modeling Alzheimer's disease and other proteopathies in vivo: is seeding the key?
Walker LC; Bian F; Callahan MJ; Lipinski WJ; Durham RA; LeVine H
Amino Acids; 2002; 23(1-3):87-93. PubMed ID: 12373522
[TBL] [Abstract][Full Text] [Related]
18. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of memory loss in Abeta and tau mouse models.
Ashe KH
Biochem Soc Trans; 2005 Aug; 33(Pt 4):591-4. PubMed ID: 16042551
[TBL] [Abstract][Full Text] [Related]
20. The role of nicotinic acetylcholine receptors in Alzheimer's disease.
Oddo S; LaFerla FM
J Physiol Paris; 2006; 99(2-3):172-9. PubMed ID: 16448808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
